Diabetes News and Research

Latest Diabetes News and Research

American Scientific Resources to acquire the intellectual property of Disintegrator home needle destruction device

American Scientific Resources, Inc. (Pink Sheets: ASFX) (the Company), today confirmed that it has signed a letter of intent to acquire the intellectual property to the Disintegrator home needle destruction device (NDD) (U.S. Patent No. 6,384,362 Patent Application No.: 09/500,504).

27 Aug 2009

BMSN and ENTB collaborate with Therinjectto to develop a new immuno-therapeutic cancer vaccine

Bio-Matrix Scientific Group, Inc. and Its majority owned subsidiary Entest BioMedical Inc. announced today they have finalized a definitive agreement with Therinject LLC for the development of a new immuno-therapeutic cancer vaccine. Therinject LLC is engaged in the development of cancer treatments utilizing immunology based approaches.

27 Aug 2009

New genetic mechanism to control body's fat-building process identified

At a time of alarming increases in obesity and associated diseases -- and fiery debates about the cost of health care -- a UCF research team has identified a new genetic mechanism that controls the body's fat-building process.

27 Aug 2009

Integrated Healthcare Association releases healthcare performance results for California

New healthcare performance results released by the Integrated Healthcare Association (IHA) include a comparison of average composite scores across eight California regions in four performance measurement domains: clinical quality, patient experience, information technology-enabled systemness, and coordinated diabetes care.

27 Aug 2009

GI Dynamics to present additional results of mechanisms of actions clinical study

GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that additional results from a previously reported clinical study regarding mechanisms of action will be presented on Saturday, August 29, 2009 by Manoel Galvao Neto, M.D., scientific coordinator, Gastro Obeso Center, Sao Paulo, Brazil and lead investigator for the study, at the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) 14th World Congress in Paris, France.

27 Aug 2009

Researchers devise a live cell morphological profiling approach using the xCELLigence RTCA System

The extent to which protein targets are modulated by drugs or small molecule compounds depends on a number of factors, including the expression levels of the target, the effective concentration of the compound, and the time needed for the compound to perturb the target. To address these restrictions, researchers Abassi et al. (1) have devised a live cell morphological profiling approach for dynamic monitoring of the effect of small molecule compounds that was based on impedance measurement of cells with the xCELLigence RTCA System of Roche Applied Science.

27 Aug 2009

Polycystic ovary syndrome in women can be relieved by acupuncture and exercise

Polycystic ovary syndrome, a common condition among women, can be relieved by the use of acupuncture and exercise. This has been shown by a recent study at the Sahlgrenska Academy, University of Gothenburg, Sweden.

27 Aug 2009

Study finds that some people eliminate more than 90 percent of the arsenic consumed in the diet

Large variations exist in peoples' ability to eliminate arsenic from the body, according to a new study that questions existing standards for evaluating the human health risks from the potentially toxic substance.

27 Aug 2009

Council for American Medical Innovation mourns the death of Senator Edward M. Kennedy

The Council for American Medical Innovation joins with members of the health community in mourning the loss of Senator Edward M. Kennedy, one of America's foremost advocates for all health care causes, particularly the medically underserved. His work in advancing medical innovation has left an indelible mark on the innovation space and transformed America's ability to invest in cures for illnesses that affect patients around the world.

27 Aug 2009

New technique for diabetes treatment may be in the offing

An exploration of the molecular links between insulin resistance and inflammation may have revealed a novel target for diabetes treatment, say scientists at the John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh of UPMC. Their findings were published earlier this month in the online version of Diabetes, one of the journals of the American Diabetes Association.

27 Aug 2009

Seminar on epigenetics and applied positive psychology for health and longevity

Jennifer Mc Donell offers her audiences a unique opportunity to hear how she survived an airplane crash. Inspiring her audiences with her experience of overcoming one difficulty after another, Jennifer is in the San Francisco Bay area September/early October.

27 Aug 2009

New website launched for comparing mortality risks by gender, age, cause of death and geographic region

A new Web site, www.DeathRiskRankings.com, developed by researchers and students at Carnegie Mellon University, allows users to query publicly available data from the United States and Europe, and compare mortality risks by gender, age, cause of death and geographic region. The Web site not only gives the risk of dying within the next year, but it also ranks the probable causes and allows for quick side-by-side comparison between groups.

26 Aug 2009

Oxygen Biotherapeutics to present at the Rodman & Renshaw Annual Global Investment Conference

Oxygen Biotherapeutics, Inc. today announced that the company will present at investor conferences in New York on Sept. 9 and Zurich on Sept. 10, 2009.

26 Aug 2009

ConjuChem Biotechnologies completes non-dilutive capital transaction

ConjuChem Biotechnologies Inc. ("ConjuChem") (TSX:CJB) today announced the completion of the transaction providing $5 million in new, non-dilutive capital to the Company. The Superior Court of Québec has approved the previously announced plan of arrangement (the "Arrangement") under section 192 of the Canada Business Corporations Act (the "CBCA") involving ConjuChem and Colabor Income Fund ("Colabor"), among others, all as fully described in ConjuChem's management information circular dated July 17, 2009.

26 Aug 2009

Study reveals benefits of balloon dilation to heart patients with moderately impaired renal function

People with kidney disease undergo balloon dilation treatment after myocardial infarction less frequently, and therefore have a poorer prognosis. This according to new clinical research published in the journal Circulation.

26 Aug 2009

Clinical study results of USANA Health Sciences products published in the Obesity and Weight Management journal

USANA Health Sciences, Inc. announced today that results of a large, third-party clinical study involving USANA products, conducted at the University of Colorado Denver (UCD), have been published in the August 2009 edition of the journal Obesity and Weight Management.

26 Aug 2009

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Amgen today announced that in a large, randomized, double-blind, placebo-controlled, Phase 3 study of patients with chronic kidney disease (CKD) (not requiring dialysis), anemia and type-2 diabetes (the Trial to Reduce Cardiovascular Endpoints with Aranesp((R)) Therapy, or TREAT), treatment of anemia with Aranesp((R) )(darbepoetin alfa) to a hemoglobin target of 13 g/dL had no statistically significant effect on either of two primary endpoints compared with placebo treatment.

26 Aug 2009

Positive results obtained from phase 3 clinical trial of lurasidone for treating schizophrenia

Dainippon Sumitomo Pharma Co., Ltd., (DSP) announced today positive results from PEARL 2 - a phase 3 clinical trial of lurasidone for the treatment of patients with schizophrenia. In this trial, both lurasidone 40 and 120 mg/day were significantly more effective than placebo for the treatment of schizophrenia. Lurasidone was well-tolerated with an overall discontinuation rate that was similar to placebo.

26 Aug 2009

New online educational forum for medical professionals from HMP Communications

HMP Communications, the authoritative source for education services targeting healthcare professionals for over two decades, announced it has added a new online educational forum at www.CardiovascularLIVE.com. The site offers video instruction and discussion forums for medical professionals.

26 Aug 2009

Research study concludes the difference in mortality between men and women depending on the type of ACS

A new study from NYU School of Medicine found that women may have a slightly higher risk of death than men in the thirty days following an acute coronary syndrome (ACS), but that these differences appear to be attributable to factors such as severity and type of ACS.

26 Aug 2009

Diabetes News and Research

Latest Diabetes News and Research

American Scientific Resources to acquire the intellectual property of Disintegrator home needle destruction device

BMSN and ENTB collaborate with Therinjectto to develop a new immuno-therapeutic cancer vaccine

New genetic mechanism to control body's fat-building process identified

Integrated Healthcare Association releases healthcare performance results for California

GI Dynamics to present additional results of mechanisms of actions clinical study

Researchers devise a live cell morphological profiling approach using the xCELLigence RTCA System

Polycystic ovary syndrome in women can be relieved by acupuncture and exercise

Study finds that some people eliminate more than 90 percent of the arsenic consumed in the diet

Council for American Medical Innovation mourns the death of Senator Edward M. Kennedy

New technique for diabetes treatment may be in the offing

Seminar on epigenetics and applied positive psychology for health and longevity

New website launched for comparing mortality risks by gender, age, cause of death and geographic region

Oxygen Biotherapeutics to present at the Rodman & Renshaw Annual Global Investment Conference

ConjuChem Biotechnologies completes non-dilutive capital transaction

Study reveals benefits of balloon dilation to heart patients with moderately impaired renal function

Clinical study results of USANA Health Sciences products published in the Obesity and Weight Management journal

Patients enrolled in the TREAT Phase 3 study treated with Aranesp to a target hemoglobin of 13 g/dL

Positive results obtained from phase 3 clinical trial of lurasidone for treating schizophrenia

New online educational forum for medical professionals from HMP Communications

Research study concludes the difference in mortality between men and women depending on the type of ACS

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Diabetes News and Research

Latest Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in